Cite

HARVARD Citation

    Gault, L. et al. (2015). A phase 2 randomized, controlled trial of the α7 agonist ABT‐126 in mild‐to‐moderate Alzheimer's dementia. Alzheimer's & dementia. 1 (1), pp. 81-90. [Online]. 
  
Back to record